Agilon Health (AGL) Short-term Investments (2022 - 2026)

Agilon Health has reported Short-term Investments for 5 years, with the latest figure at $91.4 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 60.28% year-over-year to $91.4 million; the trailing twelve-month figure through Mar 2026 stood at $91.4 million (down 60.28% YoY), and the FY2025 full-year result was $111.4 million, down 47.37% from the prior year.
• Short-term Investments for Q1 2026 stood at $91.4 million, down from $111.4 million in the prior quarter.
• The five-year high for Short-term Investments was $422.5 million in Q1 2023, with the low at $91.4 million in Q1 2026.
• Historically, Short-term Investments has averaged $279.8 million across 5 years, with a median of $288.6 million in 2022.
• Annual changes were most pronounced in 2023 — Short-term Investments soared 36.23% — and 2026, when it tumbled 60.28%.
• Agilon Health's Short-term Investments stood at $411.9 million in 2022, then fell by 7.56% to $380.8 million in 2023, then slumped by 44.39% to $211.7 million in 2024, then slumped by 47.37% to $111.4 million in 2025, then dropped by 17.95% to $91.4 million in 2026.
• The last three Short-term Investments figures came in at $91.4 million (Q1 2026), $111.4 million (Q4 2025), and $139.2 million (Q3 2025), per Business Quant data.